Studies on topical antiinflammatory corticosteroids. I. Syntheses and vasoconstrictive activities of 11 beta,17 alpha,21-trihydroxy-6 alpha-methyl-1,4-pregnadiene-3,20-dione 17-ester and 17,21-diester derivatives. 1985

S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano

UI MeSH Term Description Entries
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor

Related Publications

S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano
July 2000, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano
August 1961, Nature,
S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano
December 1989, Chemical & pharmaceutical bulletin,
S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano
March 2002, Steroids,
S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano
March 1966, Steroids,
S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano
April 1986, Chemical & pharmaceutical bulletin,
S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano
February 1966, Arzneimittel-Forschung,
S Sugai, and T Okazaki, and Y Kajiwara, and T Kanbara, and Y Naito, and S Yoshida, and S Akaboshi, and S Ikegami, and Y Kamano
January 1989, Arzneimittel-Forschung,
Copied contents to your clipboard!